WEKO3
アイテム
Clinical impact of sarcopenia and dynapenia on diabetes
https://tokushima-u.repo.nii.ac.jp/records/2007023
https://tokushima-u.repo.nii.ac.jp/records/200702355291fb4-a1b9-4155-bc2e-e1da4aaafe56
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
di_10_3_183.pdf (493 KB)
|
|
| Item type | 文献 / Documents(1) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2019-12-02 | |||||||||||||||||||||||
| アクセス権 | ||||||||||||||||||||||||
| アクセス権 | open access | |||||||||||||||||||||||
| 資源タイプ | ||||||||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||||||||
| 出版社版DOI | ||||||||||||||||||||||||
| 関連識別子 | https://doi.org/10.1007/s13340-019-00400-1 | |||||||||||||||||||||||
| 関連名称 | 10.1007/s13340-019-00400-1 | |||||||||||||||||||||||
| 出版タイプ | ||||||||||||||||||||||||
| 出版タイプ | AM | |||||||||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||||||||||||||||||||
| タイトル | ||||||||||||||||||||||||
| タイトル | Clinical impact of sarcopenia and dynapenia on diabetes | |||||||||||||||||||||||
| 著者 |
森, 博康
× 森, 博康
WEKO
732
× 黒田, 暁生
WEKO
522
× 松久, 宗英
WEKO
415
|
|||||||||||||||||||||||
| 抄録 | ||||||||||||||||||||||||
| 内容記述 | Sarcopenia as a progressive and generalized skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability, and mortality. On the other hand, an age-related decline in muscle strength prior to the reduction of muscle mass, is proposed to be "dynapenia". Sarcopenia and dynapenia has recently been recognized as a diabetic complications in type 2 diabetes. We firstly indicated that sarcopenia was frequently observed in 16.6% of patients with type 1 diabetes aged even over 40 years. Additionally, we recently reported that the prevalence rate of dynapenia was higher than sarcopenia in patients with type 2 diabetes. Chronic hyperglycemia also accelerates accumulation of advanced glycation end products (AGEs), which causes diabetic vascular complications through oxidative stress and chronic inflammation. We also demonstrated that skin autofluorescence (AF) as a marker of AGEs, was the independent determinant for skeletal muscle mass and strength in patients with type 2 diabetes and muscle strength in type 1 diabetes. Therefore, the early diagnosis of muscle weakness is essential for patients with diabetes and sustained good glycemic control with exercise and dietary intervention might be beneficial to prevent the progression of muscle weakness in these patients. | |||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||
| 主題 | Sarcopenia | |||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||
| 主題 | Dynapenia | |||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||
| 主題 | Diabetes | |||||||||||||||||||||||
| キーワード | ||||||||||||||||||||||||
| 主題 | Elderly | |||||||||||||||||||||||
| 書誌情報 |
en : Diabetology International 巻 10, 号 3, p. 183-187, 発行日 2019-06-19 |
|||||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||||
| 収録物識別子タイプ | ISSN | |||||||||||||||||||||||
| 収録物識別子 | 21901678 | |||||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||||
| 収録物識別子タイプ | ISSN | |||||||||||||||||||||||
| 収録物識別子 | 21901686 | |||||||||||||||||||||||
| 収録物ID | ||||||||||||||||||||||||
| 収録物識別子タイプ | NCID | |||||||||||||||||||||||
| 収録物識別子 | AA12503387 | |||||||||||||||||||||||
| 出版者 | ||||||||||||||||||||||||
| 出版者 | Springer Japan | |||||||||||||||||||||||
| 備考 | ||||||||||||||||||||||||
| 値 | This is a post-peer-review, pre-copyedit version of an article published in Diabetology International. The final authenticated version is available online at: https://doi.org/10.1007/s13340-019-00400-1. | |||||||||||||||||||||||
| EID | ||||||||||||||||||||||||
| 識別子 | 353231 | |||||||||||||||||||||||
| 言語 | ||||||||||||||||||||||||
| 言語 | eng | |||||||||||||||||||||||
